药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Zopiclone
Gossypol
The therapeutic efficacy of Dabigatran etexilate can be decreased when used in combination with Gossypol.
Zopiclone
Triptolide
The therapeutic efficacy of Dabigatran etexilate can be decreased when used in combination with Triptolide.
Zopiclone
Cloprostenol
The therapeutic efficacy of Dabigatran etexilate can be decreased when used in combination with Cloprostenol.
Zopiclone
Isosorbide
The therapeutic efficacy of Dabigatran etexilate can be decreased when used in combination with Isosorbide.
Zopiclone
Ulipristal
The therapeutic efficacy of Dabigatran etexilate can be decreased when used in combination with Ulipristal.
Zopiclone
Lonidamine
The therapeutic efficacy of Dabigatran etexilate can be decreased when used in combination with Lonidamine.
Zopiclone
Trestolone
The therapeutic efficacy of Dabigatran etexilate can be decreased when used in combination with Trestolone.
Zopiclone
Octylphenoxy polyethoxyethanol
The therapeutic efficacy of Dabigatran etexilate can be decreased when used in combination with Octylphenoxy polyethoxyethanol.
Zopiclone
p-Coumaric acid
The therapeutic efficacy of Dabigatran etexilate can be decreased when used in combination with p-Coumaric acid.
Zopiclone
Potassium perchlorate
Dabigatran etexilate may increase the anticoagulant activities of Potassium perchlorate.
Zopiclone
Benzylthiouracil
Benzylthiouracil may increase the anticoagulant activities of Dabigatran etexilate.
Zopiclone
Methylthiouracil
Methylthiouracil may increase the anticoagulant activities of Dabigatran etexilate.
Zopiclone
Dibromotyrosine
Dibromotyrosine may increase the anticoagulant activities of Dabigatran etexilate.
Zopiclone
Potassium Iodide
Potassium Iodide may increase the anticoagulant activities of Dabigatran etexilate.
Zopiclone
3,5-Diiodotyrosine
3,5-Diiodotyrosine may increase the anticoagulant activities of Dabigatran etexilate.
Zopiclone
Omega-3 fatty acids
Omega-3 fatty acids may increase the anticoagulant activities of Dabigatran etexilate.
Zopiclone
Omacetaxine mepesuccinate
The risk or severity of bleeding can be increased when Dabigatran etexilate is combined with Omacetaxine mepesuccinate.
Zopiclone
Loxoprofen
The risk or severity of bleeding and hemorrhage can be increased when Loxoprofen is combined with Dabigatran etexilate.
Zopiclone
Zomepirac
The risk or severity of bleeding and hemorrhage can be increased when Zomepirac is combined with Dabigatran etexilate.
Zopiclone
Flurbiprofen axetil
The risk or severity of bleeding and hemorrhage can be increased when Flurbiprofen axetil is combined with Dabigatran etexilate.